First-in-human trial shows promise for hard-to-treat ventricular tachycardia heart rhythms
A first-in-human multicenter trial involving Mayo Clinic has used a new ablation technique for patients with ventricular tachycardia, an abnormally rapid heart rhythm that is a leading cause of sudden cardiac death worldwide.